Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing
Cancer Cytopathology · 2023
DOI: 10.1002/cncy.22679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, 2023. Verfasst von Michal Marczyk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Rather than surgical resection, cytologic specimens are often used as first‐line clinical diagnostic procedures due to higher safety, speed, and cost‐effectiveness. Archival diagnostic cytology slides containing cancer can be equivalent to tissue biopsies for DNA mutation testing, but the accuracy of transcriptomic profiling by RNA sequencing (RNA‐seq) is less understood.
Methods
This study compares the results from whole transcriptome RNA‐seq and a targeted RNA‐seq assay of stained cytology smears (CS) versus matched tumor tissue samples preserved fresh‐frozen (FF) and processed as formalin‐fixed paraffin‐embedded (FFPE) sections. Cellular cytology scrapes from all 11 breast cancers were fixed and stained using three common protocols: Carnoy's (CS_C) or 95% ethanol (CS_E) fixation and then Papanicolaou stain or air‐dried then methanol fixation and DiffQuik stain (CS_DQ). Agreement between samples was assessed using Lin's concordance correlation coefficient.
Results
Library yield for CS_DQ was too low, therefore it was not sequenced. The distributions of concordance correlation coefficient of gene expression levels in comparison to FF were comparable between CS_C and CS_E, but expression of genes enriched in stroma was lower in cytosmear samples than in FF or FFPE. Six signatures showed similar concordance to FF for all methods and two were slightly worse in CS_C and CS_E. Genomic signatures were highly concordant using targeted RNA‐seq. The allele fraction of selected mutations calculated on cytosmear specimens was highly correlated with FF tissues using both RNA‐seq methods.
Conclusion
RNA can be reliably extracted from cytology smears and is suitable for transcriptome profiling or mutation detection, except for signatures of tumor stroma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
ORCID-Profile: Michal Marczyk
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Marczyk, M., Fu, C., Lau, R., Du, L., Trevarton, A. J., Sinn, B. V., Gould, R. E., Pusztai, L., Hatzis, C., & Symmans, W. F. (2023). Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing. Cancer Cytopathology. https://doi.org/10.1002/cncy.22679
Vancouver
Marczyk M, Fu C, Lau R, Du L, Trevarton AJ, Sinn BV, et al. Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing. Cancer Cytopathology. 2023. doi:10.1002/cncy.22679
BibTeX
@article{Marczyk2023,
author = {Marczyk, Michal and Fu, Chunxiao and Lau, Rosanna and Du, Lili and Trevarton, Alexander J and Sinn, Bruno V and Gould, Rebekah E and Pusztai, Lajos and Hatzis, Christos and Symmans, William Fraser},
title = {Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing},
journal = {Cancer Cytopathology},
year = {2023},
doi = {10.1002/cncy.22679}
}
EUVIMED